Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, UK.
Heart. 2010 Feb;96(4):261-2. doi: 10.1136/hrt.2009.186593. Epub 2009 Nov 5.
Despite a large volume of evidence supporting its cardioprotective properties and its other numerous established health benefits, physical activity is not a serious prescription option for the primary prevention of cardiovascular disease. On the other hand, health services increasingly focus on pharmacological prevention without considering properly the long-term consequences of medication. Ethical and feasibility considerations suggest that evidence on the protective value of physical activity may need to be evaluated using criteria different from those applying to pharmacological trials. The collateral health benefits of physical activity prescription support its use as standard option in preventive health care.
尽管有大量证据支持其心脏保护特性及其众多已确立的健康益处,但身体活动并不是预防心血管疾病的主要处方药选项。另一方面,卫生服务越来越关注药物预防,而没有适当考虑药物的长期后果。伦理和可行性考虑表明,可能需要使用不同于药物试验适用标准的标准来评估身体活动保护价值的证据。身体活动处方的附带健康益处支持将其作为预防保健的标准选择。